https://blog.seracare.com/ngs/extracting-formalin-fixed-paraffin-embedded-ffpe-nucleic-acids-for-ngshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/stained_tissue_slide_iStock-150678562.jpgstained_tissue_slide_iStock-150678562stained_tissue_slide_iStock-150678562https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2024-08-02https://blog.seracare.com/molecular-serology-blog/how-to-comply-with-clia-and-pass-pt-with-easehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/ngs/newly-published-inter-laboratory-study-provides-utility-and-validation-of-the-use-of-ctdna-reference-standardshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/RG%20interlab%201.pngRG interlab 1RG interlab 1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/mutli-center%20eval-1.jpgmutli-center eval-1mutli-center eval-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/RG%20interlab%204.pngRG interlab 4RG interlab 4https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/RG%20interlab%203.pngRG interlab 3RG interlab 3https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/RG%20interlab%202.pngRG interlab 2RG interlab 2https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/RGblog.pngRGblogRGblog2026-01-22https://blog.seracare.com/molecular-serology-blog/for-clinical-labs-ensure-access-to-reference-materialshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/ngs/two-must-see-liquid-biopsy-posters-from-amp-2018https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Use%20of%20Molecular%20Identifiers%20and%20Targeted%20NGS%20to%20Enable%20Variant%20Detection%20Below%201%20Allele%20Frequencies%20in%20Circulating%20Cell-Free%20DNA%20poster.pngUse of Molecular Identifiers and Targeted NGS to Enable Variant Detection Below 1 Allele Frequencies in Circulating Cell-Free DNA posterUse of Molecular Identifiers and Targeted NGS to Enable Variant Detection Below 1 Allele Frequencies in Circulating Cell-Free DNA posterhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Video%20Analytical%20Validation%20516x-1.jpgVideo Analytical Validation 516x-1Video Analytical Validation 516x-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Video%20Use%20Molecular%20516x.jpgVideo Use Molecular 516xVideo Use Molecular 516xhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Analytical%20Validation%20of%20Oncomine%20Breast%20cfDNA%20Assay%20v2%20poster.pngAnalytical Validation of Oncomine Breast cfDNA Assay v2 posterAnalytical Validation of Oncomine Breast cfDNA Assay v2 poster2021-10-15https://blog.seracare.com/ngs/video-see-how-an-eqa-improves-clinical-genomics-testing-with-affordable-custom-reference-standardshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Sandi-Dean-blog.pngSandi-Dean-blogSandi-Dean-blog2024-08-02https://blog.seracare.com/ngs/the-full-authority-companion-diagnostichttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/avian_influenza_flu_bird_pandemic_nature_host_imperial.jpgavian_influenza_flu_bird_pandemic_nature_host_imperialavian_influenza_flu_bird_pandemic_nature_host_imperialhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/375_250-fda_sign.jpg375_250-fda_sign375_250-fda_sign2021-10-15https://blog.seracare.com/ngs/so-many-posters-so-little-timehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/development%20NTRK.jpgdevelopment NTRKdevelopment NTRKhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/consistent%20performance.jpgconsistent performanceconsistent performancehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/validation%20novel%20pcr.jpgvalidation novel pcrvalidation novel pcrhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/non%20small%20cell%20lung%20cancer.jpgnon small cell lung cancernon small cell lung cancerhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/improving%20TMB.jpgimproving TMBimproving TMBhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/mutli-center%20eval.jpgmutli-center evalmutli-center eval2021-10-15https://blog.seracare.com/ngs/home/tabid/294/artmid/989/articleid/28/ldt-oversight-why-the-fda-makes-a-point.aspxhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/FDA_Bldg-1.jpgFDA_Bldg-1FDA_Bldg-12021-09-07https://blog.seracare.com/molecular-serology-blog/key-strategies-for-reducing-turnaround-time-in-your-clinical-labhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-09-07https://blog.seracare.com/ngs/home/tabid/294/artmid/989/articleid/24/video-interview-developing-aneuploidy-reference-materials.aspxhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/DRSeth-Video.jpgDRSeth-VideoDRSeth-Video2021-09-07https://blog.seracare.com/molecular-serology-blog/verification-part1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Email%20Components/Headers/SeraCare/Attractive%20red-haired%20scientist%20looking%20through%20a%20microscope%20in%20a%20lab-2.jpegAttractive red-haired scientist looking through a microscope in a lab-2Attractive red-haired scientist looking through a microscope in a lab-22022-06-28https://blog.seracare.com/ngs/is-your-ngs-based-assay-on-the-right-trkhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/FDA_Bldg.jpgFDA_BldgFDA_Bldghttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/ngs/clinical-laboratories-you-are-not-alone-part-2https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Buried_Businessman_iStock-157020839.jpgBuried_Businessman_iStock-157020839Buried_Businessman_iStock-157020839https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Comprehensive%20Graph.pngComprehensive GraphComprehensive Graphhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/molecular-serology-blog/for-clinical-labs-avoid-false-positives-and-negatives-by-being-a-control-freakhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/static_scientificamerican_comblogscachefile5EE1BB90-E73C-4C3A-B5F056B02A78F7AF-1.jpgstatic_scientificamerican_comblogscachefile5EE1BB90-E73C-4C3A-B5F056B02A78F7AF-1static_scientificamerican_comblogscachefile5EE1BB90-E73C-4C3A-B5F056B02A78F7AF-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-14https://blog.seracare.com/ngs/does-your-ngs-lab-struggle-with-quality-control-free-guidehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/iStock-470913486.jpgiStock-470913486iStock-470913486https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/iStock-596767998-1.jpgiStock-596767998-1iStock-596767998-12021-10-15https://blog.seracare.com/ngs/as-immunotherapy-use-rises-critical-gaps-remain-in-harmonizing-tumor-mutational-burden-measurementshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Friends%20LOGO%202013.jpgFriends LOGO 2013Friends LOGO 2013https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/molecular-serology-blog/cccdna-and-hbv-new-testing-methods-may-allow-for-earlier-non-invasive-detection-of-hepatocellular-carcinomahttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/cccDNAandHBV-1.pngcccDNAandHBV-1cccDNAandHBV-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-09-07https://blog.seracare.com/ngs/what-specifically-contributes-to-high-levels-of-ngs-accuracyhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/RG%20at%20PMWC2.pngRG at PMWC2RG at PMWC22021-10-15https://blog.seracare.com/ngs/liquid-biopsy-are-we-there-yethttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/1600x900_ALL-POSTS_TEMPLATE.jpg1600x900_ALL-POSTS_TEMPLATE1600x900_ALL-POSTS_TEMPLATEhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/ngs/sensitive-ctdna-assays-are-required-for-minimal-residual-cancer-detectionhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/simsenseq%20blog%20rg.jpgsimsenseq blog rgsimsenseq blog rghttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Sensitive%20ctDNA%20Assays%20RG%20blog.pngSensitive ctDNA Assays RG blogSensitive ctDNA Assays RG blog2021-10-15https://blog.seracare.com/ngs/aacr-2019-day-one-highlights-next-generation-car-t-cellshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/car-t%20cells.pngcar-t cellscar-t cellshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/ngs/clinical-laboratories-you-are-not-alonehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/iStock_20503680_XLARGE-2.jpgiStock_20503680_XLARGE-2iStock_20503680_XLARGE-22021-09-07https://blog.seracare.com/ngs/clinical-ngs-assay-developers-eliminate-your-specimen-search-headacheshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Remnant%20specimen%20freezer.jpgRemnant specimen freezerRemnant specimen freezerhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-14https://blog.seracare.com/ngs/fda-aacr-liquid-biopsies-in-oncology-drug-and-device-workshophttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Poisson_Figure_1.pngPoisson_Figure_1Poisson_Figure_1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Poisson_Figure_2.pngPoisson_Figure_2Poisson_Figure_22021-09-07https://blog.seracare.com/ngs/home/tabid/294/artmid/989/articleid/23/what-is-non-invasive-prenatal-testing-nipt.aspxhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Karyotype_cr-1.jpgKaryotype_cr-1Karyotype_cr-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2024-08-02https://blog.seracare.com/ngs/do-covid-19-infections-affect-nipthttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/pregnant_woman_and_doc-2.jpgpregnant_woman_and_doc-2pregnant_woman_and_doc-2https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/ngs/keys-to-better-liquid-biopsy-assay-sensitivity-amp-corporate-workshop-videohttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/bob-daber150x150.jpgbob-daber150x150bob-daber150x150https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/blog%20ctDNA%20workshop.jpgblog ctDNA workshopblog ctDNA workshophttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/tony-godfrey-150x150.jpgtony-godfrey-150x150tony-godfrey-150x1502021-10-15https://blog.seracare.com/molecular-serology-blog/verification-part3https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/Images/iStock_Purchased_Images/iStock_000081883135_XXXLarge-712392-Twitter.jpgiStock_000081883135_XXXLarge-712392-TwitteriStock_000081883135_XXXLarge-712392-Twitterhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2022-10-25https://blog.seracare.com/ngs/ebola-outbreak-2018-diagnostics-again-are-essential-to-minimize-spread-and-to-control-diseasehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/ebola%20outbreak2018%20figure2.pngebola outbreak2018 figure2ebola outbreak2018 figure2https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/ebola%20outbreak2018.pngebola outbreak2018ebola outbreak20182021-10-15https://blog.seracare.com/ngs/home/tabid/294/artmid/989/articleid/31/analytical-validation-using-biosynthetic-mutation-targets.aspxhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/KRAS_Plot-1.jpgKRAS_Plot-1KRAS_Plot-12021-09-07https://blog.seracare.com/ngs/design-and-development-of-compromised-ffpe-reference-materialshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/DR%20FFPE%20Blog%20Figure%203.pngDR FFPE Blog Figure 3DR FFPE Blog Figure 3https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/DR%20FFPE%20Blog%20Figure%201.pngDR FFPE Blog Figure 1DR FFPE Blog Figure 1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/DR%20FFPE%20Blog%20Figure%204.pngDR FFPE Blog Figure 4DR FFPE Blog Figure 4https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/DR%20FFPE%20Blog%20Figure%202.pngDR FFPE Blog Figure 2DR FFPE Blog Figure 2https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/DR%20FFPE%20Blog%20Table%201-1.pngDR FFPE Blog Table 1-1DR FFPE Blog Table 1-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/1600x900_FFPE_Chart-1.jpg1600x900_FFPE_Chart-11600x900_FFPE_Chart-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/DR%20FFPE%20Blog%20Table%202.pngDR FFPE Blog Table 2DR FFPE Blog Table 22021-10-15https://blog.seracare.com/ngs/rapid-and-early-detection-of-listeria-to-prevent-food-poisoninghttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Detection%20of%20L_%20monocytogenes.jpgDetection of L_ monocytogenesDetection of L_ monocytogeneshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Listeria%20Antibody%20Image%20iStock-113553460.jpgListeria Antibody Image iStock-113553460Listeria Antibody Image iStock-113553460https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Specificity%20Testing%20of%20Goat%20anti-Listeria%20antibody.jpgSpecificity Testing of Goat anti-Listeria antibodySpecificity Testing of Goat anti-Listeria antibodyhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-09-07https://blog.seracare.com/ngs/how-a-new-generation-of-ctdna-reference-standards-are-enabling-the-promise-of-precision-medicinehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/omosblog.pngomosblogomosbloghttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Ebook%20Cover-Sep-07-2021-01-58-13-06-AM.jpgEbook Cover-Sep-07-2021-01-58-13-06-AMEbook Cover-Sep-07-2021-01-58-13-06-AMhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/ctDNA%20Complete%20blog.pngctDNA Complete blogctDNA Complete blog2021-10-15https://blog.seracare.com/ngs/expert-opinions-on-ldt-transparency-and-standardizationhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/GW%20Report%20Blog_iStock_48420600_XXXLARGE.jpgGW Report Blog_iStock_48420600_XXXLARGEGW Report Blog_iStock_48420600_XXXLARGEhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/ngs/a-multi-lab-study-of-fusion-rna-reference-standards-using-targeted-ngs-panelshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/NGS_MainFigure_CristinaSpan%C3%B2.jpgNGS_MainFigure_CristinaSpanòNGS_MainFigure_CristinaSpanòhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Table%202-1.pngTable 2-1Table 2-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Figure%203-2-1.pngFigure 3-2-1Figure 3-2-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Figure%202-1-1.pngFigure 2-1-1Figure 2-1-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Figure%201-2.pngFigure 1-2Figure 1-22021-10-15https://blog.seracare.com/ngs/ivd-guidance-for-ngs-manufacturershttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/iStock_44373134_XXXLARGE.jpgiStock_44373134_XXXLARGEiStock_44373134_XXXLARGEhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/iStock_44373134_800x731.jpgiStock_44373134_800x731iStock_44373134_800x7312021-10-15https://blog.seracare.com/ngs/home/tabid/294/artmid/989/articleid/26/the-current-state-of-non-invasive-prenatal-testing.aspxhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/151208_baby_sm.jpg151208_baby_sm151208_baby_smhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-09-07https://blog.seracare.com/ngs/efficient-ultrasensitive-ngs-solution-profiling-ctdna-poster-talk-videohttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Asuragen-poster-video-image-1.jpgAsuragen-poster-video-image-1Asuragen-poster-video-image-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-09-07https://blog.seracare.com/ngs/home/tabid/294/artmid/989/articleid/33/circulating-tumor-dna-poster-at-keystone-symposium.aspxhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Keystone.jpgKeystoneKeystonehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-09-07https://blog.seracare.com/ngs/3-root-causes-of-downtime-for-clinical-genomic-testing-labs-and-how-to-recover-fasthttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Hand_with_tube_plain.jpgHand_with_tube_plainHand_with_tube_plain2021-10-15https://blog.seracare.com/ngs/home/tabid/294/artmid/989/articleid/32/does-synthetic-dna-sequence-behave-the-same-as-cell-line-dna.aspxhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-09-07https://blog.seracare.com/ngshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/IVF.jpgIVFIVFhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/Images/MicrosoftTeams-image.pngMicrosoftTeams-imageMicrosoftTeams-imagehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/ctDNA%20MRD%20Blood.jpgctDNA MRD BloodctDNA MRD Bloodhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Onc_2021-07%20July%2014th%20Webinar%20Panelist.jpgOnc_2021-07 July 14th Webinar PanelistOnc_2021-07 July 14th Webinar Panelisthttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/1600x900_ALL-POSTS_TEMPLATE.jpg1600x900_ALL-POSTS_TEMPLATE1600x900_ALL-POSTS_TEMPLATEhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/1600x900_ALL-POSTS_Liquid-Biopsy-4.jpg1600x900_ALL-POSTS_Liquid-Biopsy-41600x900_ALL-POSTS_Liquid-Biopsy-4https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/NGS%20Blog/BioFidelity%20Customer%20Pic.pngBioFidelity Customer PicBioFidelity Customer Pichttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/1600x900_ALL-POSTS_Liquid-Biopsy-3.jpg1600x900_ALL-POSTS_Liquid-Biopsy-31600x900_ALL-POSTS_Liquid-Biopsy-3https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/1600x900_ALL-POSTS_LB-2.jpg1600x900_ALL-POSTS_LB-21600x900_ALL-POSTS_LB-2https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/NGS%20Blog/iStock-1409734937.jpgiStock-1409734937iStock-14097349372023-01-25https://blog.seracare.com/molecular-serology-blog/is-your-lab-struggling-with-burnout-like-other-labs-heres-how-reference-materials-may-helphttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/ngs/biofidelityhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/NGS%20Blog/Biofidelity%20Quote.pngBiofidelity QuoteBiofidelity Quotehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/NGS%20Blog/BioFidelity%20Customer%20Pic.pngBioFidelity Customer PicBioFidelity Customer Pic2023-03-28https://blog.seracare.com/ngs/home/tabid/294/artmid/989/articleid/12/what-is-precision-medicine.aspxhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/DNA_London_Museum.jpgDNA_London_MuseumDNA_London_Museum2021-09-07https://blog.seracare.com/ngs/introducing-a-new-reference-material-for-kras-molecular-testinghttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/KRAS%20Status_EGFR.jpgKRAS Status_EGFRKRAS Status_EGFRhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/iStock-477996737.jpgiStock-477996737iStock-4779967372021-10-15https://blog.seracare.com/ngs/american-association-for-cancer-research-2016-ctdna-highlightshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/160502_AACR_Graphic2.jpg160502_AACR_Graphic2160502_AACR_Graphic2https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-09-07https://blog.seracare.com/ngs/nipt-and-pgt-at-the-virtual-conferences-2020https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Virtual%20conference.jpgVirtual conferenceVirtual conferencehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/molecular-serology-blog/how-low-can-you-go-performance-at-lower-levels-is-criticalhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Email%20Components/Body/Maine/Low%20Positive%20Blog%20(8).pngLow Positive Blog (8)Low Positive Blog (8)https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2022-06-30https://blog.seracare.com/ngs/home/tabid/294/artmid/989/articleid/22/association-for-molecular-pathology-2015-conference-highlights.aspxhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/LungFNA_Slide.jpgLungFNA_SlideLungFNA_Slidehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-09-07https://blog.seracare.com/ngs/how-many-target-copies-are-present-in-your-plasma-dna-samplehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/How-Sera-Care-Can-Help-FW-Right.jpgHow-Sera-Care-Can-Help-FW-RightHow-Sera-Care-Can-Help-FW-Righthttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/graph%201-Bettegowda%20et%20al%20Sci%20Trans%20Med.pnggraph 1-Bettegowda et al Sci Trans Medgraph 1-Bettegowda et al Sci Trans Medhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/plasma_dna_Sample_iStock-166539104.jpgplasma_dna_Sample_iStock-166539104plasma_dna_Sample_iStock-166539104https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Graph%202%20-%20Mutant%20Allel%20Frequency%20Copies.pngGraph 2 - Mutant Allel Frequency CopiesGraph 2 - Mutant Allel Frequency Copies2021-10-15https://blog.seracare.com/molecular-serology-blog/looking-for-the-silver-lining-in-the-cloud-of-sars-cov-2-emerging-variantshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/ACE2-1209159939-696x522.jpgACE2-1209159939-696x522ACE2-1209159939-696x522https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/ngs/customer-data-use-of-seraseq-ctdna-reference-samples-to-validate-detection-of-low-frequency-variants-in-a-cfdna-based-ngs-lung-cancer-panelhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/customer-data-table-1.jpgcustomer-data-table-1customer-data-table-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/customer-data-figure-1.jpgcustomer-data-figure-1customer-data-figure-12021-10-15https://blog.seracare.com/ngs/home/tabid/294/artmid/989/articleid/29/newsworthy-science-in-2015.aspxhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Year_2015-1.jpgYear_2015-1Year_2015-12021-09-07https://blog.seracare.com/ngs/workshop-video-two-experts-take-on-clinical-genomics-qc-and-standardization-at-amphttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/john-pfeifer-m_d_-ph_d150x150.jpgjohn-pfeifer-m_d_-ph_d150x150john-pfeifer-m_d_-ph_d150x150https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/greg-tsongalis150x150.jpggreg-tsongalis150x150greg-tsongalis150x150https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/AMP%20Workshop%20QC%20Program%20Part%201%20346x.pngAMP Workshop QC Program Part 1 346xAMP Workshop QC Program Part 1 346xhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/molecular-serology-blog/seracare-introduces-accuplex-zika-reference-materialhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/160506_Zika_virus-1.jpg160506_Zika_virus-1160506_Zika_virus-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-09-07https://blog.seracare.com/ngs/development-of-a-novel-reference-material-for-mrd-monitoring-assayshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/MRD%20Table%203.pngMRD Table 3MRD Table 3https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/ctDNA%20MRD%20Blood.jpgctDNA MRD BloodctDNA MRD Bloodhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/image-png-Aug-13-2021-05-46-24-89-PM.pngimage-png-Aug-13-2021-05-46-24-89-PMimage-png-Aug-13-2021-05-46-24-89-PMhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/MRD%20Table%202.pngMRD Table 2MRD Table 2https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/image-png-Aug-13-2021-05-27-50-40-PM.pngimage-png-Aug-13-2021-05-27-50-40-PMimage-png-Aug-13-2021-05-27-50-40-PMhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/MRD%20Table%201.pngMRD Table 1MRD Table 1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/image-png-Aug-13-2021-05-47-02-48-PM.pngimage-png-Aug-13-2021-05-47-02-48-PMimage-png-Aug-13-2021-05-47-02-48-PM2021-10-15https://blog.seracare.com/ngs/methylated-dna-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Email%20Components/CTAs/CTAs/SERACARE.pngSERACARESERACAREhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Videos/Webinars/Methylated%20DNA%20Sidebar.pngMethylated DNA SidebarMethylated DNA Sidebarhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Videos/Webinars/CG%20Blog%201.pngCG Blog 1CG Blog 1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/Images/MicrosoftTeams-image.pngMicrosoftTeams-imageMicrosoftTeams-imagehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Videos/Webinars/CG%20Blog%202.pngCG Blog 2CG Blog 22023-03-02https://blog.seracare.com/ngs/home/tabid/294/artmid/989/articleid/6/video-interview-why-use-reference-materials-for-precision-medicine.aspxhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/DrRussel-Interview.jpgDrRussel-InterviewDrRussel-Interviewhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-09-07https://blog.seracare.com/ngs/evolution-of-non-invasive-prenatal-testing-nipt-testinghttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/istock-48289588-medium.jpgistock-48289588-mediumistock-48289588-medium2022-12-20https://blog.seracare.com/ngs/home/tabid/294/artmid/989/articleid/20/circulating-tumor-dna-liquid-biopsy-needs-reference-standards.aspxhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/DNA_Scarf_Marni-rot.jpgDNA_Scarf_Marni-rotDNA_Scarf_Marni-rothttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-09-07https://blog.seracare.com/ngs/home/tabid/294/artmid/989/articleid/42/mary-claire-king-at-the-european-society-for-human-genetics-2016.aspxhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/160603_King1.jpg160603_King1160603_King1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/160603_King1-1.jpg160603_King1-1160603_King1-12021-09-07https://blog.seracare.com/ngs/seracare-introduces-accuplex-zika-reference-materialhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/160506_Zika_virus.jpg160506_Zika_virus160506_Zika_virushttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-09-07https://blog.seracare.com/ngs/efficient-ultrasensitive-ngs-solution-profiling-ctdna-poster-videohttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Asuragen-poster-video-image-1.jpgAsuragen-poster-video-image-1Asuragen-poster-video-image-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/ngs/dr-andrea-ferreira-gonzalez-on-the-seven-benefits-of-clinical-genomics-universal-standardizationhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Gonzalez_Andrea-vcu-1.jpgGonzalez_Andrea-vcu-1Gonzalez_Andrea-vcu-12021-10-15https://blog.seracare.com/molecular-serology-blog/improve-the-reliability-of-your-zika-diagnostic-assayshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/zika_Virus_Vaccines_iStock-654573066-1.jpgzika_Virus_Vaccines_iStock-654573066-1zika_Virus_Vaccines_iStock-654573066-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-14https://blog.seracare.com/ngs/previewing-the-american-association-for-cancer-research-2016-conference-aacr16https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/AACR20161.jpgAACR20161AACR20161https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-09-07https://blog.seracare.com/ngs/how-am-i-going-to-test-my-assay-should-i-use-patient-samples-or-biosynthetic-materialshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/DNA-genetic-Biotechnology-iStock-690730626.jpgDNA-genetic-Biotechnology-iStock-690730626DNA-genetic-Biotechnology-iStock-6907306262021-10-15https://blog.seracare.com/ngs/precision-medicine-and-clinical-labs-aacr-dinner-seminar-wrap-uphttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/aacrvipdinner.jpgaacrvipdinneraacrvipdinnerhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/ngs/developing-a-rock-solid-lung-cancer-assay-part2https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/iStock-902874274.jpgiStock-902874274iStock-902874274https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/ngs/3-steps-for-building-a-bulletproof-clinical-ngs-assay-step-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/DNA_London_Museum-1.jpgDNA_London_Museum-1DNA_London_Museum-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-14https://blog.seracare.com/ngs/home/tabid/294/artmid/989/articleid/19/association-of-molecular-pathology-meeting-nov-4-7-2015.aspxhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/AMP_Invite.jpgAMP_InviteAMP_Invitehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-09-07https://blog.seracare.com/ngs/home/tabid/294/artmid/989/articleid/7/introducing-seracares-genomic-precision-blog.aspxhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/logo.pnglogologo2021-09-07https://blog.seracare.com/ngs/home/tabid/294/artmid/989/articleid/34/oncology-regulatory-framework-for-ngs-webinar-friday-feb-26-2016.aspxhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/TOMABio.jpgTOMABioTOMABio2021-09-07https://blog.seracare.com/ngs/3-steps-for-building-a-bulletproof-clinical-ngs-assay-step-2https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/dna-1-1600x1600.jpgdna-1-1600x1600dna-1-1600x16002021-10-14https://blog.seracare.com/ngs/with-so-many-options-how-do-you-select-the-best-ngs-cancer-assayhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/directions-iStock-585777094.jpgdirections-iStock-585777094directions-iStock-585777094https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Observed-variant-frequency-chart_emf.jpgObserved-variant-frequency-chart_emfObserved-variant-frequency-chart_emfhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Fusion-heat-map-graph.jpgFusion-heat-map-graphFusion-heat-map-graph2024-08-02https://blog.seracare.com/ngs/this-is-the-number-one-risk-to-your-clinical-sequencing-assayhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/iStock-474360451-461242-edited.jpgiStock-474360451-461242-editediStock-474360451-461242-editedhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/Images/iStock_Purchased_Images/iStock-474360451-461242-edited.jpgiStock-474360451-461242-editediStock-474360451-461242-edited2021-10-15https://blog.seracare.com/ngs/keep-calm-and-standardize-onhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/GWebinar%20Trends%20in%20Clinical%20NGS%20QC%20Management.pngGWebinar Trends in Clinical NGS QC ManagementGWebinar Trends in Clinical NGS QC Managementhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/keep%20calm.pngkeep calmkeep calm2021-10-15https://blog.seracare.com/ngs/the-first-comprehensive-myeloid-cancer-reference-materials-for-ngs-assayshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/CEBPA%20Graph_Myeloid%20Graph.pngCEBPA Graph_Myeloid GraphCEBPA Graph_Myeloid Graphhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Myekoid%20Cancer%20Image%202_iStock-585047884.jpgMyekoid Cancer Image 2_iStock-585047884Myekoid Cancer Image 2_iStock-585047884https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Myekoid%20Cancer_iStock-585047884.jpgMyekoid Cancer_iStock-585047884Myekoid Cancer_iStock-5850478842021-10-15https://blog.seracare.com/ngs/building-and-implementing-liquid-biopsy-assays-with-industrys-most-patient-like-reference-materialshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/liquid-biopsy-blog.pngliquid-biopsy-blogliquid-biopsy-bloghttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/poster%20inset%20EricaSteinNIST-1.jpgposter inset EricaSteinNIST-1poster inset EricaSteinNIST-12021-10-15https://blog.seracare.com/ngs/a-multi-lab-study-of-fusion-rna-reference-sstandards-using-amplicon-and-hybrid-capture-based-targeted-ngs-panelshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Table%202-1.pngTable 2-1Table 2-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Figure%201-1.pngFigure 1-1Figure 1-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Figure%203-2-1.pngFigure 3-2-1Figure 3-2-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Figure%202-1-1.pngFigure 2-1-1Figure 2-1-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/LabResearch300x130.pngLabResearch300x130LabResearch300x1302021-09-07https://blog.seracare.com/ngs/futureproof-your-clinical-genomics-labs-compliance-3-tips-to-prepare-for-potential-requirementshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Dr__Holding_older_hand_iStock_71912497_LARGE.jpgDr__Holding_older_hand_iStock_71912497_LARGEDr__Holding_older_hand_iStock_71912497_LARGE2021-10-15https://blog.seracare.com/ngs/twists-and-turns-that-lead-from-curiosity-driven-research-to-innovative-diagnosticshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/rna_molcule_blog.jpgrna_molcule_blogrna_molcule_blog2021-10-15https://blog.seracare.com/ngs/cccdna-and-hbv-new-testing-methods-may-allow-for-earlier-non-invasive-detection-of-hepatocellular-carcinomahttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/cccDNAandHBV.pngcccDNAandHBVcccDNAandHBV2021-10-15https://blog.seracare.com/ngs/if-i-call-out-of-tune-would-mutations-stand-up-and-walk-out-on-mehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/NGS%20Assay%20Validation%20Daber%20ebook.pngNGS Assay Validation Daber ebookNGS Assay Validation Daber ebookhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/OutofTuneMutations1.pngOutofTuneMutations1OutofTuneMutations1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/OutofTuneMutations2.pngOutofTuneMutations2OutofTuneMutations22024-08-02https://blog.seracare.com/ngs/podcast-target-the-tumor-mutational-burden-and-pursue-harmonizationhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Friends%20LOGO%20PODCAST-1.jpgFriends LOGO PODCAST-1Friends LOGO PODCAST-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/mark-stewart-100x100.jpgmark-stewart-100x100mark-stewart-100x1002021-10-15https://blog.seracare.com/ngs/home/tabid/294/artmid/989/articleid/27/sanger-versus-next-generation-sequencing-infographic.aspxhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Sanger_vs_NGS_low.pngSanger_vs_NGS_lowSanger_vs_NGS_lowhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-09-07https://blog.seracare.com/ngs/home/tabid/294/artmid/989/articleid/30/ldt-oversight-counterpoint-tempering-fda-arguments.aspxhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/FDA_Bldg2.jpgFDA_Bldg2FDA_Bldg2https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-09-07https://blog.seracare.com/molecular-serology-blog/verification-part5https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/Images/iStock_Purchased_Images/iStock_000022457561_XXXLarge.jpgiStock_000022457561_XXXLargeiStock_000022457561_XXXLargehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Email%20Components/CTAs/CTAs/WP%20Download-1.pngWP Download-1WP Download-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2023-02-06https://blog.seracare.com/ngs/cnvs-and-tumor-profiling-new-cnv-specific-reference-material-for-gene-amplifications-in-breast-lung-and-brain-cancerhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Lung-Cancer-Image-iStock-492387248.jpgLung-Cancer-Image-iStock-492387248Lung-Cancer-Image-iStock-4923872482021-10-15https://blog.seracare.com/ngs/accelerating-liquid-biopsy-assay-developmenthttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Russell%20NGDX%2017%20workshop%20-1.jpgRussell NGDX 17 workshop -1Russell NGDX 17 workshop -1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/T790M%20digital%20PCR%20data-1b.jpgT790M digital PCR data-1bT790M digital PCR data-1bhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/ctDNA%20v2%20extraction%20chart.jpgctDNA v2 extraction chartctDNA v2 extraction charthttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Russell%20NGDX%2017%20workshop%20.jpgRussell NGDX 17 workshop Russell NGDX 17 workshop https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/T790M%20cytosine%20deamination-1.jpgT790M cytosine deamination-1T790M cytosine deamination-12021-10-15https://blog.seracare.com/ngs/diagnostic-testing-schemes-for-ntrk-cancers-all-roads-lead-to-ngshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/iStock_000046561376_XXXLarge.jpgiStock_000046561376_XXXLargeiStock_000046561376_XXXLargehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/RG%20Figure%201.jpgRG Figure 1RG Figure 12026-01-22https://blog.seracare.com/ngs/making-the-shift-from-technological-innovation-to-operational-excellence-delivering-on-the-promise-of-next-generation-sequencing-for-personalized-medicinehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/JPM_Reagent_Drift_Q30.pngJPM_Reagent_Drift_Q30JPM_Reagent_Drift_Q30https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/JPM-66-percent-labs-use-homebrew.pngJPM-66-percent-labs-use-homebrewJPM-66-percent-labs-use-homebrewhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/JPM-how-often-use-positive-controls.pngJPM-how-often-use-positive-controlsJPM-how-often-use-positive-controlshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/JPM.jpgJPMJPMhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/JPM%20figure%201%20workflow.pngJPM figure 1 workflowJPM figure 1 workflowhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/JPM-Sequencing_Metrics.pngJPM-Sequencing_MetricsJPM-Sequencing_Metrics2021-10-15https://blog.seracare.com/ngs/how-to-resolve-the-challenges-of-mrdhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Figure%201%20Yves%20blog%20part2.pngFigure 1 Yves blog part2Figure 1 Yves blog part22021-10-15https://blog.seracare.com/ngs/challenges-of-preimplantation-genetic-testinghttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/IVF.jpgIVFIVFhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/embryonic%20development%20(003).pngembryonic development (003)embryonic development (003)2021-10-15https://blog.seracare.com/ngs/first-of-its-kind-survey-to-assess-qc-habits-labs-running-clinical-ngs-assayshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/GWsurvey.jpgGWsurveyGWsurveyhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/ngs/a-new-focus-on-implementing-clinical-genomicshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/GW%20screenshot%202017.jpgGW screenshot 2017GW screenshot 2017https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/ngs/to-realize-the-potential-of-liquid-biopsies-focus-on-higher-quality-research-and-clinical-data-setshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/liquid-biopsy-ai-thumb-m.jpgliquid-biopsy-ai-thumb-mliquid-biopsy-ai-thumb-mhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/ngs/your-lab-is-growing-heres-how-to-train-your-new-staff-quicklyhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/GettyImages-172595263.jpgGettyImages-172595263GettyImages-1725952632021-10-15https://blog.seracare.com/molecular-serology-blog/3-tips-for-reducing-test-repeats-and-lab-downtimehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/www_cidrap_umn_edusitesdefaultfilespublicstylesthumbnailpublicimagesnewsun0228948-1.jpgwww_cidrap_umn_edusitesdefaultfilespublicstylesthumbnailpublicimagesnewsun0228948-1www_cidrap_umn_edusitesdefaultfilespublicstylesthumbnailpublicimagesnewsun0228948-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/ngs/faq-what-to-do-when-your-ngs-assay-fails-to-detect-a-variant-contained-in-seraseq-reference-materialshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/FAQ%20blog%20NGS%20assay.pngFAQ blog NGS assayFAQ blog NGS assayhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Ebook%20Cover-Sep-07-2021-01-54-18-08-AM.jpgEbook Cover-Sep-07-2021-01-54-18-08-AMEbook Cover-Sep-07-2021-01-54-18-08-AM2021-10-14https://blog.seracare.com/ngs/aacr-2019-day-three-understanding-t-cell-therapy-for-unique-cancer-mutationshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/T-cell%20.jpegT-cell T-cell https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/ngs/liquid-biopsy-dr-claudia-vollbrechthttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/1600x900_ALL-POSTS_Liquid-Biopsy-4.jpg1600x900_ALL-POSTS_Liquid-Biopsy-41600x900_ALL-POSTS_Liquid-Biopsy-42021-10-15https://blog.seracare.com/ngs/home/tabid/294/artmid/989/articleid/38/the-fda-ngs-based-oncology-panels-workshop.aspxhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/FDA_logo.jpgFDA_logoFDA_logohttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-09-07https://blog.seracare.com/ngs/improve-the-reliability-of-your-zika-diagnostic-assayshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/zika_Virus_Vaccines_iStock-654573066.jpgzika_Virus_Vaccines_iStock-654573066zika_Virus_Vaccines_iStock-654573066https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/ngs/higher-quality-for-better-qchttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Heather%20Buckley%20headshot%20small.jpgHeather Buckley headshot smallHeather Buckley headshot small2021-10-15https://blog.seracare.com/ngs/3-steps-for-building-a-bulletproof-clinical-ngs-assay-step-3https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/dna-sequence-1599x1070.jpgdna-sequence-1599x1070dna-sequence-1599x1070https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.comhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/NGS%20Blog/BioFidelity%20Customer%20Pic.pngBioFidelity Customer PicBioFidelity Customer Pichttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/Images/iStock_Purchased_Images/iStock_000022457561_XXXLarge.jpgiStock_000022457561_XXXLargeiStock_000022457561_XXXLargehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/ctDNA%20MRD%20Blood.jpgctDNA MRD BloodctDNA MRD Bloodhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/Images/iStock_Purchased_Images/PCR_sample.jpgPCR_samplePCR_samplehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Onc_2021-07%20July%2014th%20Webinar%20Panelist.jpgOnc_2021-07 July 14th Webinar PanelistOnc_2021-07 July 14th Webinar Panelisthttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/Images/iStock_Purchased_Images/iStock_000081883135_XXXLarge-712392-Twitter.jpgiStock_000081883135_XXXLarge-712392-TwitteriStock_000081883135_XXXLarge-712392-Twitterhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/Images/COVID-19%20Image.jpgCOVID-19 ImageCOVID-19 Imagehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Stock%20Images/Uncategorized%20Stock%20Images/Images/AdobeStock_181601820.jpegAdobeStock_181601820AdobeStock_181601820https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/NGS%20Blog/iStock-1409734937.jpgiStock-1409734937iStock-1409734937https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/Images/MicrosoftTeams-image.pngMicrosoftTeams-imageMicrosoftTeams-image2022-12-16https://blog.seracare.com/ngs/amp-2017-highlights-the-epigenetic-basis-of-common-human-diseasehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Andy%20Feinberg.gifAndy FeinbergAndy Feinberg2021-10-15https://blog.seracare.com/ngs/dr.-andrea-ferreira-gonzalez-on-the-seven-benefits-of-clinical-genomics-universal-standardizationhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Gonzalez_Andrea-vcu.jpgGonzalez_Andrea-vcuGonzalez_Andrea-vcu2021-09-07https://blog.seracare.com/ngs/presenting-ntrk-reference-materials-for-global-assay-standardization-at-aacr-2019https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/digital%20PCR%20quantitation.pngdigital PCR quantitationdigital PCR quantitationhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/15%20NTRK%20fusion%20RNAs%20.png15 NTRK fusion RNAs 15 NTRK fusion RNAs https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/NTRK%20gene.jpgNTRK geneNTRK gene2026-05-06https://blog.seracare.com/ngs/so-you-want-to-monitor-measurable-residual-disease-what-are-the-challengeshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Laboratory%20Pipette%20with%20Blue%20Liquid%20Over%20Glass%20Test%20Tubes_.jpegLaboratory Pipette with Blue Liquid Over Glass Test Tubes_Laboratory Pipette with Blue Liquid Over Glass Test Tubes_https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/ngs/home/tabid/294/artmid/989/articleid/21/posters-from-amp-2015-available-for-download.aspxhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/AMP_Posters.jpgAMP_PostersAMP_Posters2021-09-07https://blog.seracare.com/ngs/what-lessons-for-liquid-biopsy-have-been-learned-from-fetal-aneuploidy-testinghttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Error_Report_Graph.pngError_Report_GraphError_Report_Graphhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-09-07https://blog.seracare.com/ngs/home/tabid/294/artmid/989/articleid/14/precision-medicine-perspective.aspxhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Condie_Carmack.jpgCondie_CarmackCondie_Carmackhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-09-07https://blog.seracare.com/ngs/microsatellite-instability-testing-to-predict-immunotherapeutic-responsehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Microsatellite%20Instability%20Testing%20blog%20table.pngMicrosatellite Instability Testing blog tableMicrosatellite Instability Testing blog tablehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Microsatellite%20Instability%20Testing%20blog.pngMicrosatellite Instability Testing blogMicrosatellite Instability Testing blog2024-08-02https://blog.seracare.com/ngs/home/tabid/294/artmid/989/articleid/37/circulating-tumor-dna-reference-materials.aspxhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/ctDNA_Blend.jpgctDNA_BlendctDNA_Blendhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-09-07https://blog.seracare.com/ngs/what-is-non-invasive-prenatal-testing-nipthttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Karyotype_cr-1.jpgKaryotype_cr-1Karyotype_cr-12024-08-02https://blog.seracare.com/molecular-serology-blog/ebola-outbreak-2018-diagnostics-again-are-essential-to-minimize-spread-and-to-control-diseasehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/ebola%20outbreak2018%20figure2-1.pngebola outbreak2018 figure2-1ebola outbreak2018 figure2-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/ebola%20outbreak2018-1.pngebola outbreak2018-1ebola outbreak2018-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-14https://blog.seracare.com/molecular-serology-blog/nrl-webinarhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Email%20Components/CTAs/CTAs/SERACARE.pngSERACARESERACAREhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Molecular%20Blog/WATCH%20NOW%20(1).pngWATCH NOW (1)WATCH NOW (1)https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/Images/COVID-19%20Image.jpgCOVID-19 ImageCOVID-19 Imagehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2023-02-23https://blog.seracare.com/ngs/methylated-dna-2https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/NGS%20Blog/iStock-1409734937.jpgiStock-1409734937iStock-1409734937https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Email%20Components/CTAs/CTAs/SERACARE.pngSERACARESERACAREhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Molecular%20Blog/Meth%20DNA%20Blog%202.pngMeth DNA Blog 2Meth DNA Blog 22023-01-26https://blog.seracare.com/ngs/assessing-rna-extraction-with-ffpe-fusion-rna-reference-materialshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/tumor_Shutterstock_featured.jpgtumor_Shutterstock_featuredtumor_Shutterstock_featuredhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Dan%20B%20blog%20March%202020%20table%201.pngDan B blog March 2020 table 1Dan B blog March 2020 table 1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Dan%20B%20blog%20March%202020%20figure%201.pngDan B blog March 2020 figure 1Dan B blog March 2020 figure 1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Dan%20B%20blog%20March%202020%20table%202-1.pngDan B blog March 2020 table 2-1Dan B blog March 2020 table 2-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/ngs/womens-healthhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Women%20HCPS.jpgWomen HCPSWomen HCPShttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/tests.jpgteststestshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/molecular-serology-blog/verification-part2https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Stock%20Images/Uncategorized%20Stock%20Images/Images/AdobeStock_181601820.jpegAdobeStock_181601820AdobeStock_181601820https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2022-08-30https://blog.seracare.com/ngs/home/tabid/294/artmid/989/articleid/36/highlights-from-the-2016-molecular-medicine-tri-conference.aspxhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-09-07https://blog.seracare.com/ngs/advancing-immuno-oncology-biomarker-validation-with-industrys-first-ngs-based-tmb-reference-materials-0https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Table%201-2.pngTable 1-2Table 1-2https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Product%20Listing-2.pngProduct Listing-2Product Listing-2https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Table%202-1-1.pngTable 2-1-1Table 2-1-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Advancing%20I-O%20Figure%201.jpgAdvancing I-O Figure 1Advancing I-O Figure 1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/graphs-Aug-31-2020-08-41-06-93-PM.pnggraphs-Aug-31-2020-08-41-06-93-PMgraphs-Aug-31-2020-08-41-06-93-PMhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Table%203-4.pngTable 3-4Table 3-4https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Advancing%20I-O%20Table%201B.pngAdvancing I-O Table 1BAdvancing I-O Table 1Bhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/ngs/reference-materials-for-your-unique-reproducibility-needshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Darts_iStock_80048433_XLARGE.jpgDarts_iStock_80048433_XLARGEDarts_iStock_80048433_XLARGEhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Blog_October.pngBlog_OctoberBlog_October2021-09-07https://blog.seracare.com/molecular-serology-blog/4-best-practices-for-qc-in-a-clinical-testing-lab-to-ensure-accurate-resultshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/ngs/multiplexed-reference-materials-as-controls-for-cardiomyopathy-diagnostic-next-generation-sequencinghttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/iStock-516727646.jpgiStock-516727646iStock-5167276462021-10-15https://blog.seracare.com/ngs/liquid-biopsy-professor-sandi-deanshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/1600x900_ALL-POSTS_LB-2.jpg1600x900_ALL-POSTS_LB-21600x900_ALL-POSTS_LB-22021-10-15https://blog.seracare.com/molecular-serology-blog/verification-part4https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Email%20Components/CTAs/CTAs/WP%20Download-1.pngWP Download-1WP Download-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/Images/iStock_Purchased_Images/PCR_sample.jpgPCR_samplePCR_sample2022-12-21https://blog.seracare.com/ngs/home/tabid/294/artmid/989/articleid/16/video-what-are-the-sources-of-variability-in-ffpe-material.aspxe-materialhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/SeraCare_Vid.jpgSeraCare_VidSeraCare_Vid2021-09-07https://blog.seracare.com/ngs/home/tabid/294/artmid/989/articleid/35/molecular-tri-conference-preview-san-francisco-ca-march-7-11-2016.aspxhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/160229_Triconference.jpg160229_Triconference160229_Triconference2021-09-07https://blog.seracare.com/ngs/prevent-assay-drift-in-your-clinical-ngs-assay-by-avoiding-2-common-mistakeshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Chemistry_Research_Rows_of_Test__TubesClose_jpg.jpgChemistry_Research_Rows_of_Test__TubesClose_jpgChemistry_Research_Rows_of_Test__TubesClose_jpg2021-10-15https://blog.seracare.com/ngs/anti-tropomyosin-receptor-tyrosine-kinase-therapies-and-ntrk-fusion-testing-a-new-paradigm-for-identifying-and-managing-a-class-of-rare-pediatric-and-adult-cancer-patientshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/NTRK_Cancer_Types.jpgNTRK_Cancer_TypesNTRK_Cancer_Typeshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/NTRK%20fusion%20gene%20list.pngNTRK fusion gene listNTRK fusion gene listhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/ngs/developing-a-rock-solid-lung-cancer-assayhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/LungCancer_iStock-837105016.jpgLungCancer_iStock-837105016LungCancer_iStock-8371050162021-10-15https://blog.seracare.com/ngs/real-world-needs-for-genetic-testing-reference-materialshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Image2.pngImage2Image2https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Image1.pngImage1Image1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/open_peapods_iStock-598142800.jpgopen_peapods_iStock-598142800open_peapods_iStock-598142800https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/4_20_17%20Blog%20Table.png4_20_17 Blog Table4_20_17 Blog Table2021-10-15https://blog.seracare.com/ngs/aacr-2019-day-two-learning-about-the-microbiome-in-immuno-oncologyhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/A-speficic-antibody-(yellow)-blocks-the-binding-site-of-PD-1-(red)-on-a-T-cell-to-avoid-the-down-regulation-of-the-immune-system-by-cancer-cells_-1053.jpegA-speficic-antibody-(yellow)-blocks-the-binding-site-of-PD-1-(red)-on-a-T-cell-to-avoid-the-down-regulation-of-the-immune-system-by-cancer-cells_-1053A-speficic-antibody-(yellow)-blocks-the-binding-site-of-PD-1-(red)-on-a-T-cell-to-avoid-the-down-regulation-of-the-immune-system-by-cancer-cells_-1053https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/A-speficic-antibody-(yellow)-blocks-the-binding-site-of-PD-1-(red)-on-a-T-cell-to-avoid-the-down-regulation-of-the-immune-system-by-cancer-cells_-1053-1.jpegA-speficic-antibody-(yellow)-blocks-the-binding-site-of-PD-1-(red)-on-a-T-cell-to-avoid-the-down-regulation-of-the-immune-system-by-cancer-cells_-1053-1A-speficic-antibody-(yellow)-blocks-the-binding-site-of-PD-1-(red)-on-a-T-cell-to-avoid-the-down-regulation-of-the-immune-system-by-cancer-cells_-1053-12021-10-15https://blog.seracare.com/ngs/highlights-from-the-precision-medicine-world-congresshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/assay%20validation%20and%20revalidation.pngassay validation and revalidationassay validation and revalidationhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/How%20do%20we%20use%20data.pngHow do we use dataHow do we use datahttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/improving%20survival%20with%20Combination%20therapy.pngimproving survival with Combination therapyimproving survival with Combination therapyhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/PMWC.pngPMWCPMWChttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/ngs/home/tabid/294/artmid/989/articleid/15/genetic-profiling-of-pediatric-oncology-patients-.aspxhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/151005_JAMA_Screenshot.png151005_JAMA_Screenshot151005_JAMA_Screenshot2021-09-07https://blog.seracare.com/ngs/how-to-validate-your-labs-clinical-genomics-tests-affordably-and-revalidatehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/cancer_cell_in_blood_iStock_000004443081_Double.jpgcancer_cell_in_blood_iStock_000004443081_Doublecancer_cell_in_blood_iStock_000004443081_Doublehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-14https://blog.seracare.com/molecular-serology-bloghttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/Images/iStock_Purchased_Images/PCR_sample.jpgPCR_samplePCR_samplehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Email%20Components/Body/Maine/Low%20Positive%20Blog%20(8).pngLow Positive Blog (8)Low Positive Blog (8)https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Stock%20Images/Uncategorized%20Stock%20Images/Images/AdobeStock_181601820.jpegAdobeStock_181601820AdobeStock_181601820https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/Images/iStock_Purchased_Images/iStock_000081883135_XXXLarge-712392-Twitter.jpgiStock_000081883135_XXXLarge-712392-TwitteriStock_000081883135_XXXLarge-712392-Twitterhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Email%20Components/Headers/SeraCare/Attractive%20red-haired%20scientist%20looking%20through%20a%20microscope%20in%20a%20lab-2.jpegAttractive red-haired scientist looking through a microscope in a lab-2Attractive red-haired scientist looking through a microscope in a lab-2https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/Images/COVID-19%20Image.jpgCOVID-19 ImageCOVID-19 Imagehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/Images/iStock_Purchased_Images/iStock_000022457561_XXXLarge.jpgiStock_000022457561_XXXLargeiStock_000022457561_XXXLarge2022-12-16https://blog.seracare.com/molecular-serology-blog/rapid-and-early-detection-of-listeria-to-prevent-food-poisoninghttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Specificity%20Testing%20of%20Goat%20anti-Listeria%20antibody-1.jpgSpecificity Testing of Goat anti-Listeria antibody-1Specificity Testing of Goat anti-Listeria antibody-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Detection%20of%20L_%20monocytogenes-1.jpgDetection of L_ monocytogenes-1Detection of L_ monocytogenes-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Listeria%20Antibody%20Image%20iStock-113553460-1.jpgListeria Antibody Image iStock-113553460-1Listeria Antibody Image iStock-113553460-1https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-09-07https://blog.seracare.com/ngs/3-tips-for-reducing-the-costs-of-running-your-clinical-genomics-lab-while-maintaining-accuracy-and-efficiencyhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/iStock_000081883135_XXXLarge-712392-Twitter.jpgiStock_000081883135_XXXLarge-712392-TwitteriStock_000081883135_XXXLarge-712392-Twitterhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCare2021-10-15https://blog.seracare.com/ngs/genomic-testing-to-support-new-therapies-for-advanced-cancerhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/image-png-Aug-05-2021-04-40-44-74-PM.pngimage-png-Aug-05-2021-04-40-44-74-PMimage-png-Aug-05-2021-04-40-44-74-PMhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/image-png-Jul-30-2021-06-16-47-84-PM.pngimage-png-Jul-30-2021-06-16-47-84-PMimage-png-Jul-30-2021-06-16-47-84-PMhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Onc_2021-07%20July%2014th%20Webinar%20Panelist.jpgOnc_2021-07 July 14th Webinar PanelistOnc_2021-07 July 14th Webinar Panelisthttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/image-png-Jul-30-2021-06-14-18-11-PM.pngimage-png-Jul-30-2021-06-14-18-11-PMimage-png-Jul-30-2021-06-14-18-11-PM2021-10-15https://blog.seracare.com/ngs/amp-reference-material-forum-themeshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/AMP%202017%20Website%20Bannerv5FINAL.jpgAMP 2017 Website Bannerv5FINALAMP 2017 Website Bannerv5FINAL2021-10-15https://blog.seracare.com/ngs/liquid-biopsy-professor-ed-schuuringet-0-0https://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/1600x900_ALL-POSTS_Liquid-Biopsy-3.jpg1600x900_ALL-POSTS_Liquid-Biopsy-31600x900_ALL-POSTS_Liquid-Biopsy-32021-10-15https://blog.seracare.com/ngs/you-cant-validate-everything-can-youhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/You%20cant%20validate%20everything%20blog%20graphic.jpgYou cant validate everything blog graphicYou cant validate everything blog graphichttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/You%20cant%20validate%20everything%20blog%20graphic-1.jpgYou cant validate everything blog graphic-1You cant validate everything blog graphic-12021-10-15https://blog.seracare.com/ngs/as-to-myeloid-diseases-make-a-habit-of-three-thingshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Hematoxylin-eosin-stain-bone-marrow-image.jpgHematoxylin-eosin-stain-bone-marrow-imageHematoxylin-eosin-stain-bone-marrow-imagehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/structure-of-FLT3-receptor.jpgstructure-of-FLT3-receptorstructure-of-FLT3-receptorhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/USCS-Genome-browser-view.pngUSCS-Genome-browser-viewUSCS-Genome-browser-viewhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/DNA-Tablets-iStock-545591338.jpgDNA-Tablets-iStock-545591338DNA-Tablets-iStock-5455913382021-10-15https://blog.seracare.com/ngs/how-the-most-patient-like-ctdna-reference-materials-solve-three-problemshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/DNA%20non-stabilizer%20form%20chart.pngDNA non-stabilizer form chartDNA non-stabilizer form charthttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/ctDNA%20size%20distribution%20chart.pngctDNA size distribution chartctDNA size distribution chart2021-10-15https://blog.seracare.com/ngs/ground-control-to-major-tom-use-controls-and-keep-your-assay-running-onhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Mean%20Read%20Depth%20Run%20Failures.pngMean Read Depth Run FailuresMean Read Depth Run Failureshttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/majortom.jpgmajortommajortomhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/Experience%20QC%20Stops%20at%20least%20Monthly.pngExperience QC Stops at least MonthlyExperience QC Stops at least Monthly2021-10-15https://blog.seracare.com/molecular-serology-blog/how-third-party-controls-can-help-keep-your-clinical-lab-within-budget-without-sacrificing-qualityhttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Logos/SeraCare/SeraCare.pngSeraCareSeraCarehttps://20300467.fs1.hubspotusercontent-na1.net/hubfs/20300467/0.%20Blogs/Imported_Blog_Media/clinicalomics_comfilegetimage2092-1.jpegclinicalomics_comfilegetimage2092-1clinicalomics_comfilegetimage2092-12021-10-15